Download
pntd.0008472.pdf 989,28KB
WeightNameValue
1000 Titel
  • SARS-CoV-2 infection in China—Before the pandemic
1000 Autor/in
  1. Liang, Huiying |
  2. Zheng, Lingling |
  3. Xia, Huimin |
  4. Tang, Jinling |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-06
1000 Erschienen in
1000 Quellenangabe
  • 14(8):e0008472
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1371/journal.pntd.0008472 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410170/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • ABSTRACT: In order to rapidly inform polices in the international response to the ongoing pandemic of coronavirus disease 19 (COVID-19), we summarize in this review current evidence on epidemiological and clinical features of the infection, transmission routes, problems of nucleic-acid testing, the epidemiological trend in China and impact of interventional measures, and some lessons learned. We concluded that the epidemic is containable with traditional nonpharmacological interventions, mainly through social distancing and finding and isolating suspected patients and close contacts. Nonpharmacological interventions are the only effective measures currently accessible and have suppressed some 90% of the infections in China. Close contacts are the major mechanism of transmission, which makes it possible to control this epidemic through nonpharmacological methods. Nucleic-acid testing alone may miss some 50% of infected patients, and other methods such as chest computerized tomography (CT) or serology should be considered to supplement molecular testing. The development of vaccines and drugs is important, but hesitation to make use of nonpharmacological interventions may mean missing golden opportunities for effective actions. AUTHOR SUMMARY: In particular, we summarize the origin of the pathogen, epidemiological and clinical features of the infection, transmission routes and transmissibility, problems of nucleic-acid testing and diagnostic criteria, the epidemiological trend in China and its relation to interventional measures, and special issues including infection in doctors and children and the role of vaccines versus traditional nonpharmacological interventions in control of the epidemic. Importantly, evidence clearly suggests the following: The epidemic is containable with traditional nonpharmacological interventions, largely by social distancing and testing and isolation of suspected patients and close contacts. Nonpharmacological interventions are the most immediately accessible effective measures and have helped suppress some 90% of infections in China. Close contacts through droplets and fomites are the major mechanism of transmission, and asymptomatic infections and aerosols are unlikely important in spreading the virus. This is a major feature of the virus and explains why it is containable through nonpharmacological methods. Nucleic-acid testing alone may miss many truly infected patients, and chest CT should always be used if available to supplement molecular testing. Development of vaccines and drugs are important, but any hesitation to use nonpharmacological interventions may mean missing golden opportunities for useful actions against the epidemic.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Infectious disease epidemiology
lokal Corticosteroid therapy
lokal Antiviral therapy
lokal Quarantines
lokal Virus testing
lokal Respiratory infections
lokal China
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-9987-8002|https://frl.publisso.de/adhoc/uri/WmhlbmcsIExpbmdsaW5n|https://frl.publisso.de/adhoc/uri/WGlhLCBIdWltaW4=|https://frl.publisso.de/adhoc/uri/VGFuZywgSmlubGluZw==
1000 Label
1000 Förderer
  1. National Key Research and Development Program of China |
1000 Fördernummer
  1. 2019YFB1404803
1000 Förderprogramm
  1. -
1000 Dateien
  1. SARS-CoV-2 infection in China—Before the pandemic
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Key Research and Development Program of China |
    1000 Förderprogramm -
    1000 Fördernummer 2019YFB1404803
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6428299.rdf
1000 Erstellt am 2021-06-22T18:44:01.471+0200
1000 Erstellt von 218
1000 beschreibt frl:6428299
1000 Bearbeitet von 317
1000 Zuletzt bearbeitet 2022-08-16T10:02:39.302+0200
1000 Objekt bearb. Tue Aug 16 10:02:25 CEST 2022
1000 Vgl. frl:6428299
1000 Oai Id
  1. oai:frl.publisso.de:frl:6428299 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source